Efficacy and Safety of Immunotherapeutic Strategies for the Treatment of MART-1-Expressing Melanoma: Systematic Review of Clinical Trials
Simple Summary Immunotherapy has become an important treatment strategy for patients with advanced melanoma. Melanoma antigen recognized by T cells 1 (MART-1) has been extensively investigated as a target for a variety of immunotherapeutic approaches, including DNA- and peptide-based vaccines, adoptive cell therapies,...